Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Inclusion Criteria: * Male or female subjects, age \> 18 years * Primary hypercholesterolaemia with CV risk \> 20% (as defined in European Guidelines ) and/or type II diabetes and/or a history of CHD or other established atherosclerotic disease. Subjects may be lipid-lowering therapy naïve or have been treated for min. 4 weeks with a 'start' dose of any lipid-lowering therapy, which was ineffective. * Naïve subjects must have completed 12-weeks dietary counselling before this visit. Exclusion Criteria: * Known heterozygous or homozygous familial hypercholesterolaemia or known type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia). * Documented secondary hypercholesterolaemia of any cause other than named in inclusion criteria 3. * Serious or unstable medical condition * Statin contraindication